The CHMP plays a significant role in the approval and regulation of medications used in gynecology. This includes treatments for conditions such as endometriosis, polycystic ovary syndrome (PCOS), and various cancers of the reproductive system. The committee's approval ensures that these medications meet stringent standards for safety and effectiveness, thereby improving patient outcomes.